Merck And Co Inc Drug Patent Portfolio

Merck And Co Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Merck And Co Inc News

Merck & Co., Inc. stock (US58933Y1055): Can Keytruda's leading position maintain its strength?

19 Apr, 2026

Merck & Co., Inc. stock (US58933Y1055): Can Keytruda's leading position drive significant growth?

19 Apr, 2026

Study reveals that Merck's leading cancer medication exceeded $200,000 annually during Trump's presidency - ICIJ

17 Apr, 2026

Understanding Keytruda: Mechanism of Action and Current Attention in Cancer Treatment | Health News

17 Apr, 2026

See More